EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, SYMQY: Symbio Pharmaceuticals Ltd

06 Nov 2025
LAST:

0.6370

CHANGE:
 0.22		OPEN:
0.6423		HIGH:
0.7108		ASK:
0.0000		VOLUME:
4.5K
CHG(%):
25.30		PREV:
0.8528		LOW:
0.6370		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:Symbio Pharmaceuticals Ltd
About:SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally. It offers SyB L-0501, an anti-cancer agent for the treatment of non-Hodgkin's lymphoma, multiple myeloma, chronic lymphocytic leukemia, and relapsed/refractory diffuse large B-cell lymphoma; SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid administration under the TREAKISYM name. The company also engages in the development of SyB L-1101, an intravenous formulation, which completed Phase III clinical trial for the treatment of higher-risk myelodysplastic syndromes (HR-MDS); and SyB C-1101, an oral formulation that is in Phase II clinical trial in combination with AZA to treat HR-MDS. In addition, it is involved in the development SyB V-1901, an antiviral drug. SymBio Pharmaceuticals Limited was incorporated in 2005 and is based in Tokyo, Japan.
Sector:Healthcare
Address:Toranomon 30 Mori Building, Tokyo, Japan, 105-0001
Website:https://www.symbiopharma.com
CIK:0001625751
ISIN:US87150Y1001
FIGI:BBG007XM3W32

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.8635.0%
MA10:0.9955.1%
Week High:0.7111.6%
Week Low:0.640.0%